The apoptosis pathway that is regulated by the Bcl-2 protein family is critical for lymphocyte development, maintenance of peripheral tolerance and prevention of autoimmunity [99], and Bcl-2 family antagonism has been demonstrated to be a potential approach for the treatment of autoimmune diseases [100]. This evidence concerns the gene BCL2 and autoimmune disease.